ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2202

Classification Criteria for Sjögren’s Syndrome: Comparison of the Performance of the 2002 American-European Consensus Group Criteria (AECG) and the 2012 ACR Criteria

Elke Theander1, Peter Olsson2 and Thomas Mandl3, 1Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Section of Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden, 3Dept of Rheumatology, Skåne University Hospital Malmo, Lund University, Sweden, Malmö, Sweden

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and classification criteria

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome - Clinical

Session Type: Abstract Submissions (ACR)

Background/Purpose: To assess level of agreement between 2002 AECC and 2012 ACR criteria for primary Sjögren’s Syndrome syndrome (pSS) within the Malmö Sjögren’s Syndrome Registry

Methods : The Malmö Sjögren’s Syndrome Registry was established 1984. Patients not fulfilling the AECG criteria were after 2002 designated as having Sicca-Syndrome in contrast to pSS. To date 368 pSS according to AECG and 264 Sicca patients are registered.  Here the ACR-criteria ocular staining score (OSS) ³3 was substituted by van Bijsterveld score ³3. An inter-criteria reliability analysis with Kappa statistic was performed to determine classification consistency.

Results : Of 264 Sicca patients not fulfilling AECG, 81% had sufficient data available to make a decision about fulfilling the ACR criteria. Seven patients (2.7%) fulfilled the ACR critiera but not AECG. All of these fulfilled the ACR criteria due to high titres of ANA and positive RF. None was positive for anti-Ro or La or had a positive salivary gland biopsy. Nor did they have signs of lymphoma risk or had developed lymphoma. Thus, in 97% of the evaluable sicca patients the two criteria sets agreed. Of 368 fulfilling AECG, 268 (73%) had information on all ACR items available, 309 (84%) had sufficient information to evaluate fulfillment of the ACR criteria set. Forty-eight (15%) of AECG positive patients were negative when applying the ACR criteria. 261 of 309 evaluable AECG positive patients were positive according to the ACR criteria, resulting in a consensus in 85%. A calculated kappa-value of 0.781 signals a substantial agreement between the two criteria sets.Amongst the patients not identified by the ACR-criteria there were several with known risk factors for development of lymphoma (table 1). One lymphoma patients (pos biopsy, low C3, high titre ANA but no SSA/SSB or RF, low OSS) was negative in the ACR criteria. Seventeen of the 46 patients not identified by the ACR criteria were previously included in an analysis of germinal center (GC) formation in salivary gland biopsies.  Two of these (12%) were positive for GC. These patients with low complement levels, polyneuropathy, low salivary flow were missed applying the ACR criteria due to lack of severe eye disease and SSA/SSB.

Characteristics of 46 patients fulfilling AECG- but not ACR-criteria (n/% of available)

Pos autoimmune sialadenitis

32 (70%)

Pos SSA/SSB

13 (29%)

Low C3 (<0.8 g/l)

  4 (11,4%)

Low C4 (<0.20 g/l)

  8 (23%)

High IgG (>16 g/l)

  7 (17%)

Parotid swelling

  9 (21%)

Purpura Waldenstršm

  2 (4%)

Cryoglobulinemia

  2 (4%)

Low CD4/CD8 ratio

  1 (2%)

Lymphoma

  1 (2%)

Conclusion : The 2002 AECG and 2012 ACR criteria for SS identify mainly the same patient population (Kappa: 0.781), when applied to the Malmö SS registry containing 386 pSS and 264 sicca syndrome patients. A subgroup of patients lacking SSA/SSB antibodies can be catched only by the ACR criteria. The patients classified as Sjögren’s syndrome by the ACR-criteria in our sicca-cohort had mild disease. On the other hand, several patients with high risk disease manifestations such as hypocomplementemia, GC formation or parotid swelling were missed using the ACR criteria because they lacked severe keratoconjunctivitis sicca. Sensitivity and specificity of the ACR criteria were 85% and 97% respectively.


Disclosure:

E. Theander,
None;

P. Olsson,
None;

T. Mandl,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/classification-criteria-for-sjogrens-syndrome-comparison-of-the-performance-of-the-2002-american-european-consensus-group-criteria-aecg-and-the-2012-acr-criteria/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology